Jade Biosciences/$JBIO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Jade Biosciences
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
Ticker
$JBIO
Sector
Primary listing
Employees
55
Headquarters
Website
Jade Biosciences Metrics
BasicAdvanced
$956m
-
-$2.11
-
-
Price and volume
Market cap
$956m
52-week high
$28.00
52-week low
$6.61
Average daily volume
918k
Financial strength
Current ratio
14.288
Quick ratio
13.964
Long term debt to equity
0.229
Total debt to equity
0.286
Interest coverage (TTM)
-37.11%
Profitability
Effective tax rate (TTM)
-0.06%
Management effectiveness
Valuation
Price to book
2.68
Price to tangible book (TTM)
2.68
Price to free cash flow (TTM)
-7.232
Free cash flow yield (TTM)
-13.83%
Free cash flow per share (TTM)
-2.226
Growth
Jade Biosciences News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs